Meet an Unreasonable Venture
Debut Biotechnology
Creating peak-performing products that are rooted in science and clinical testing with impeccable sustainability credentials
Debut Biotech uses advanced biotechnology to discover and produce high-performance, clinically backed ingredients for beauty, food, and nutrition. Its process combines AI-driven ingredient discovery with a capital-light, vertically integrated model to deliver novel, higher performing ingredients in formulation faster than traditional methods. With early commercial traction and an expanding customer pipeline, Debut is building a differentiated portfolio of bioactives to transform consumer product categories through performance-driven innovation.
Notable Achievements
- Named one of the TIME100 Most Innovative Companies of 2025.
- Raised $80M in venture capital and private equity.
- Has seen revenue 100-300% YOY for 3 years.
Currently Operating in 77 Regions
More Ventures in Health
Get the Unreasonable Newsletter
Get monthly updates on Debut Biotechnology and all of the other ventures working to solve global challenges.